NK-1 Receptor Antagonist for the Treatment of Itch in Epidermolysis Bullosa (EB) Patients

We are currently looking for subjects who meet the following criteria:

  • Have a clinical diagnosis of EB by a local dermatologist
  • Are age 13 or older and are willing to give consent, or if a minor, their parents or guardians are willing to give consent
  • Medically stable to travel to Stanford University Medical Center
  • Suffer from chronic and constant itch
  • Resident in the USA


If you meet the above criteria, you may be eligible to come to Stanford University for this trial.  The study will involve blood and urine tests.  We will pay the travel and laboratory expenses related to this trial.

If you would like more information, or have any questions regarding our study and/or our eligibility criteria, please contact our study coordinator, Melissa Barriga at (650) 850-1674 or mbarriga@stanford.edu

For information about your rights as a research participant, please contact, please contact the Stanford Institutional Review Board (IRB) at 650-723-5244, or toll-free at 1-866-680-2906.